DEC 5 AIDAC

On Friday, December 5, 2014 the Anti-Infective Drugs Advisory Committee (AIDAC) will discuss new drug application 206494 for ceftazidime-avibactam for injection, submitted  by Cerexa Inc., for the proposed indications of: Complicated Intra-abdominal Infections, Complicated Urinary Tract Infections, including Acute Pyelonephritis and Limited Use Indication: Aerobic Gram-negative Infections with Limited Treatment Options.

See the Announcement